POU5F1 and breast cancer: Using the mouse models of mammary tumors and tibial osteolysis, we examined the effects of Oct4 and OAC2 in BALB/c mice, in which 50 μL of the concentrated Oct4 CM or OAC2 CM by 10-fold was administered daily as an intravenous injection.